What question did this study set out to answer?

To review the genomic landscape of prostate cancer and assess the implications for precision therapy.

March 17, 2026npj Precision OncologyOpen Access

Genomic landscape and precision therapy in prostate cancer: current status and future directions

View Full Paper

Ask AI

Bookmark

Authors

JLJohn A. LigonUniversity of Mississippi Medical Center SAShashi AnandJackson Memorial Hospital SSSeema SinghUniversity of Mississippi Medical Center

Discussion

Member takes

Implication

This review highlights genomic insights and precision therapies in prostate cancer, suggesting personalized approaches could enhance patient outcomes.

Key Points

To review the genomic landscape of prostate cancer and assess the implications for precision therapy.
Overview of genomic profiling techniques
Discussion of molecular alterations in prostate cancer
Analysis of therapeutic strategies using biomarkers
Examination of challenges in genomic diversity
Identified frequent alterations in oncogenes and tumor suppressors
Highlight the role of androgen receptor signaling in therapy resistance
Noted significant intratumor and intertumor genomic diversity
Emphasized the importance of biomarker-driven treatments for improved outcomes

Cite This Study

Ligon et al. (2026) studied this question.

synapsesocial.com/papers/69b8ef36deb47d591b8c5464 https://doi.org/10.1038/s41698-026-01368-3

View Full Paper

Ask AI

Bookmark

Implication

This review highlights genomic insights and precision therapies in prostate cancer, suggesting personalized approaches could enhance patient outcomes.

Genomic landscape and precision therapy in prostate cancer: current status and future directions

Discussion

Member takes

Implication

Key Points

Cite This Study

Genomic landscape and precision therapy in prostate cancer: current status and future directions

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider